Dibenzothiophene

Dibenzothiophene

SCHEMBL9934048

B.c1ccc2c(c1)sc1ccccc12

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.93
ALDH1A1 P00352 6/20 0.58
MAPT P10636 5/20 0.58
RAB9A P51151 3/20 0.58
HPGD P15428 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
KDM4E B2RXH2 2/20 0.45
LOXL2 Q9Y4K0 1/20 0.44
ALOX15 P16050 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
POLB P06746 1/20 0.42
CYP2A6 P11509 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MCL1 Q07820 1/20 0.41
IKBKB O14920 1/20 0.41
LIMK1 P53667 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dibenzothiophene SCHEMBL13294 0.97 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL30167635 0.97 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL14659543 0.97 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL29696490 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL10943387 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL28979299 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL3101427 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL3101419 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL21121001 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL28979045 0.93 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017302-A Bi(S,S-dioxo-dibenzothiophene) five-membered ring compound and preparation method and application thereof UNIV SOUTH CHINA TECH 2015-11-04 CN claimed
CN-105017302-A Bi(S,S-dioxo-dibenzothiophene) five-membered ring compound and preparation method and application thereof UNIV SOUTH CHINA TECH 2015-11-04 CN disclosed
US-8664263-B2 Stilbene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-04 US disclosed
US-8580980-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-11-12 US disclosed
US-20120184755-A1 Stilbene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-07-19 US disclosed
US-20120157694-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184755-A1 Stilbene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device ESR1, ESR2, NR2E3 GPR3 1654/4885ALDH1A1 29/4885MAPT 2632/4885
US-20120157694-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device CYP1A1, CRY1, AHR GPR3 608/4885ALDH1A1 14/4885MAPT 3454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.